Target intelligence / Profile preview

Paracrine signaling modulation of inflammation

Molecular classification
Cytokine, Chemokine, Receptor, Growth factor, Lipid mediator
01

Overview

Paracrine signaling modulation of inflammation is a fundamental biological process where cells secrete biochemical mediators to influence the inflammatory state of neighboring cells within the local microenvironment (StatPearls, 2023). This localized communication is primarily mediated by cytokines, chemokines, and lipid mediators that bind to specific receptors on adjacent cells, initiating intracellular signaling cascades that amplify or resolve the immune response (Nature Reviews Immunology, 2021). In pathological conditions such as rheumatoid arthritis or Crohn's disease, these paracrine loops become dysregulated, leading to chronic tissue destruction and persistent leukocyte infiltration (PubMed, 2022). Therapeutic intervention typically involves the use of monoclonal antibodies or decoy receptors designed to intercept these secreted signals before they can activate neighboring cells (NIH, 2023). By disrupting these local interactions, drugs can effectively dampen the overall inflammatory burden, though this often results in a compromised ability of the host to respond to pathogens. Understanding the spatial dynamics of these signals is crucial for developing targeted therapies that minimize systemic side effects while maximizing local efficacy.

Other names
Local inflammatory signalingParacrine cytokine signalingIntercellular inflammatory communicationJuxtacrine and paracrine inflammatory axis
02

Mechanism of action

Neutralization of secreted paracrine ligands or competitive blockade of their cognate receptors on neighboring cells to interrupt local inflammatory feedback loops and recruitment cascades.

03

Biological functions

Signal transductionImmune responseInflammationCell-cell communicationChemotaxis
04

Disease associations

InflammationAutoimmune diseaseCancerCardiovascular diseaseRheumatoid arthritisInflammatory bowel disease
05

Safety considerations

Systemic immunosuppressionIncreased risk of serious opportunistic infectionsImpaired wound healingInjection site or infusion reactionsPotential for malignancy with long-term use
06

Interacting drugs

Infliximab

5 more in the full profile.

07

Biomarkers

C-reactive protein (CRP)Interleukin-6 (IL-6) serum levelsTumor necrosis factor-alpha (TNF-alpha) levelsErythrocyte sedimentation rate (ESR)Calprotectin

Beyond the preview

Go deeper on Paracrine signaling modulation of inflammation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Paracrine signaling modulation of inflammation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call